 Recombinant Proteins
"Recombinant Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins prepared by recombinant DNA technology.
| Descriptor ID |
D011994
|
| MeSH Number(s) |
D12.776.828
|
| Concept/Terms |
Recombinant Proteins- Recombinant Proteins
- Proteins, Recombinant
- Proteins, Biosynthetic
- Biosynthetic Proteins
Proteins, Recombinant DNA- Proteins, Recombinant DNA
- DNA Proteins, Recombinant
- Recombinant DNA Proteins
- DNA Recombinant Proteins
- Proteins, DNA Recombinant
- Recombinant Proteins, DNA
|
Below are MeSH descriptors whose meaning is more general than "Recombinant Proteins".
Below are MeSH descriptors whose meaning is more specific than "Recombinant Proteins".
This graph shows the total number of publications written about "Recombinant Proteins" by people in this website by year, and whether "Recombinant Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 30 | 30 | | 1997 | 0 | 29 | 29 | | 1998 | 1 | 42 | 43 | | 1999 | 2 | 28 | 30 | | 2000 | 4 | 28 | 32 | | 2001 | 3 | 33 | 36 | | 2002 | 1 | 42 | 43 | | 2003 | 6 | 36 | 42 | | 2004 | 4 | 38 | 42 | | 2005 | 7 | 57 | 64 | | 2006 | 4 | 38 | 42 | | 2007 | 3 | 33 | 36 | | 2008 | 4 | 35 | 39 | | 2009 | 5 | 32 | 37 | | 2010 | 6 | 31 | 37 | | 2011 | 3 | 29 | 32 | | 2012 | 2 | 26 | 28 | | 2013 | 3 | 34 | 37 | | 2014 | 3 | 36 | 39 | | 2015 | 3 | 31 | 34 | | 2016 | 3 | 19 | 22 | | 2017 | 2 | 25 | 27 | | 2018 | 5 | 24 | 29 | | 2019 | 4 | 18 | 22 | | 2020 | 3 | 21 | 24 | | 2021 | 3 | 12 | 15 | | 2022 | 0 | 4 | 4 | | 2023 | 0 | 9 | 9 | | 2024 | 1 | 4 | 5 | | 2025 | 0 | 9 | 9 | | 2026 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Recombinant Proteins" by people in Profiles.
-
Bermack C, Singh S, Pei G, Patel SP, Wang L, Yee C. First-in-human use of recombinant IL-7 to potentiate antigen-specific T cell therapy: a single patient case study. J Immunother Cancer. 2026 Apr 30; 14(4).
-
Sagel SD, Vu P, Heltshe SL, Solomon GM, Kelly A, Pittman J, Rosenfeld M, Ratjen F. Elexacaftor/tezacaftor/ivacaftor is associated with long-term reduction in use of chronic respiratory therapies in cystic fibrosis. J Cyst Fibros. 2026 May; 25(3):450-456.
-
Weitz JI, Kithcart AP, O'Brien MP, Levy O, Marin E, Onisko M, Mohammadi KA, Li D, Meagher KA, Chang HH, Olenchock BA, Gutstein DE, Segers A, Roberts RS, Bonaca MP, Raskob GE. Efficacy and safety of REGN9933A2 and REGN7508Cat for preventing postoperative venous thromboembolism (ROXI-VTE-I and ROXI-VTE-II): two randomised, open-label, phase 2 trials. Lancet. 2025 Nov 29; 406(10519):2551-2563.
-
Chaudhry-Waterman N, Schardt TQ, Soderstrom RM, Warren BB, Buckvold S, Morgan G, Kim JS. Catheter-Directed Bivalirudin for Local Anticoagulation and Clot Dissolution in Children Requiring Mechanical Circulatory Support. ASAIO J. 2026 02 01; 72(2):e24-e28.
-
Buckner TW, Kessler C, Castaman G, Hermans C, Jiménez-Yuste V, Mahlangu J, Miesbach W, Oldenburg J, Recht M, Valentino LA, Wheeler AP, Pipe SW. Pain Reduction Following Eptacog Beta Treatment of Bleeding Episodes in Adolescents and Adults With Haemophilia A or B Complicated by Inhibitors. Haemophilia. 2025 Jul; 31(4):713-721.
-
Kahan RH, Palmer SK, Garoosi K, Gomez DA, Khechoyan DY, French B, Lowe K, Nguyen PD. Alveolar Bone Grafting: Outcomes Utilizing Synthetic HA/TCP and rhBMP-2 versus Autologous Graft Types. Plast Reconstr Surg. 2026 01 01; 157(1):129-138.
-
Gupta S, Kaunfer SA, Chen KL, Dias JA, Vijayan A, Rajasekaran A, Prosek JM, Truong HL, Wood A, Bassil C, Renaghan AD, Shah CV, Zhang J, Glezerman I, Carlos C, Kelly K, Passero CJ, Drappatz J, Abudayyeh A, Shin DS, Sperati CJ, Yelvington BJ, Kanduri SR, Neyra JA, Edmonston D, Shirali AC, Bansal A, Geara A, Mithani Z, Ziolkowski SL, Rashidi A, Jakubowski J, Pujari A, Bond DA, Dotson E, Wall S, Patton J, Barreto JN, Herrmann SM, Sheikh MS, Baz R, Lee J, Lucchesi N, Kolman M, Rasheed MA, Afzal A, Kang D, Mahesh A, Hsu RK, Nicolaysen A, Tefera K, Schretlen C, Miller RM, Velez JC, Flannery AH, Aklilu AM, Anand S, Chandrasekhara S, Donley V, Patel A, Ni J, Krishnamurthy S, Ali R, Yilmam OA, Wells SL, Ortega JL, Green-Lingren OL, Leaf RK, Sise ME, Nayak L, LaCasce AS, Leung N, Leaf DE. Glucarpidase for treatment of high-dose methotrexate toxicity. Blood. 2025 Apr 24; 145(17):1858-1869.
-
Gilbert JS, Pollyea DA, Walsh TJ, Groll AH, Lazarus HM. Recombinant Myeloid Hematopoietic Growth Factors and Clinical Stimulation of Acute Myeloid Leukemia Cells: A Narrative Review. Acta Haematol. 2026; 149(2):202-210.
-
Tran N, Redzic JS, Eisenmesser EZ, Holyoak T. The structure of the Gemella haemolysans M26 IgA1 protease trypsin-like domain. Acta Crystallogr F Struct Biol Commun. 2025 Apr 01; 81(Pt 4):124-129.
-
Cao M, Katial R, Liu Y, Lu X, Gu Q, Chen C, Liu K, Zhu Z, Marshall MR, Yu Y, Wang Z. Safety, efficacy, and immunogenicity of a novel IgG degrading enzyme (KJ103): results from two randomised, blinded, phase 1 clinical trials. Gene Ther. 2025 05; 32(3):223-236.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|